EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment

Jie Wang, Qi Huang, Kun He, Junpeng Li, Tengfei Guo, Yang Yang, Zengping Lin, Songye Li, Greet Vanderlinden, Yiyun Huang, Koen Van Laere, Yihui Guan und 4 weitere

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.13817 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Jie Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Positron-Emission Tomography, Receptor, Metabotropic Glutamate 5, Cognitive Dysfunction. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Science Foundation of China, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Metabotropic glutamate receptor 5 (mGluR5) is involved in regulating integrative brain function and synaptic transmission. Aberrant mGluR5 signaling and relevant synaptic failure play a key role in the pathophysiological mechanism of Alzheimer's disease (AD). METHODS Ten cognitively impaired (CI) individuals and 10 healthy controls (HCs) underwent [ 18 F]SynVesT‐1 and [ 18 F]PSS232 positron emission tomography (PET)/magnetic resonance to assess synaptic density and mGluR5 availability. The associations between mGluR5 availability and synaptic density were examined. A mediation analysis was performed to investigate the possible mediating effects of mGluR5 availability and synaptic loss on the relationship between amyloid deposition and cognition. RESULTS CI patients exhibited lower mGluR5 availability and synaptic density in the medial temporal lobe than HCs. Regional synaptic density was closely associated with regional mGluR5 availability. mGluR5 availability and synaptic loss partially mediated the relationship between amyloid deposition and cognition. CONCLUSIONS Reductions in mGluR5 availability and synaptic density exhibit similar spatial patterns in AD and are closely linked. Highlights Cognitively impaired patients exhibited lower mGluR5 availability and synaptic density in the medial temporal lobe than HCs. Reductions in mGluR5 availability and synaptic density exhibit similar spatial patterns in AD. Regional synaptic density was closely associated with regional mGluR5 availability. mGluR5 availability and synaptic loss partially mediated the relationship between amyloid deposition and global cognition. With further research, modulating mGluR5 availability might be a potential therapeutic strategy for improving synaptic function in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron-Emission TomographyReceptor, Metabotropic Glutamate 5Cognitive DysfunctionHumansMaleFemaleAgedAlzheimer DiseaseMagnetic Resonance ImagingSynapsesMiddle AgedBrain

Stichwörter der Autor:innen

Alzheimer's diseasePET/MRamyloid depositioncognitionmGluR5 availabilitysynaptic density

Substanzen

Receptor, Metabotropic Glutamate 5GRM5 protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China.
  • Beijing United Imaging Research Institute of Intelligent Imaging, Beijing, China.
  • Central Research Institute, United Imaging Healthcare Group Co., Ltd, Shanghai, China.
  • Department of Radiology and Biomedical Imaging, PET Center, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Department of Imaging and Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium.

ORCID-Profile: Fang Xie

Förderung

  • National Key R&D Program of China
  • National Science Foundation of China
  • Shanghai Sailing Program
  • Huashan Hospital, Fudan University
  • Shanghai Municipal Key Clinical Specialty
  • Shanghai Municipal Science and Technology Major Project
  • ZJLab Clinical Research Plan of SHDC
  • RN acknowledges Swiss Center for Applied Human Toxicology

Zitieren

APA

Wang, J., Huang, Q., He, K., Li, J., Guo, T., Yang, Y., Lin, Z., Li, S., Vanderlinden, G., Huang, Y., Van Laere, K., Guan, Y., Guo, Q., Ni, R., Li, B., & Xie, F. (2024). Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment. Alzheimer's & Dementia. https://doi.org/10.1002/alz.13817

Vancouver

Wang J, Huang Q, He K, Li J, Guo T, Yang Y, et al. Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment. Alzheimer's & Dementia. 2024. doi:10.1002/alz.13817

BibTeX
@article{Wang2024,
  author = {Wang, Jie and Huang, Qi and He, Kun and Li, Junpeng and Guo, Tengfei and Yang, Yang and Lin, Zengping and Li, Songye and Vanderlinden, Greet and Huang, Yiyun and Van Laere, Koen and Guan, Yihui and Guo, Qihao and Ni, Ruiqing and Li, Binying and Xie, Fang},
  title = {Presynaptic density determined by SV2A PET is closely associated with postsynaptic metabotropic glutamate receptor 5 availability and independent of amyloid pathology in early cognitive impairment},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.13817}
}
Kostenlos starten →